Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284

1.

The characteristics, treatment patterns, and outcomes of older adults aged 80 and over with multiple myeloma.

Fiala MA, Foley NC, Zweegman S, Vij R, Wildes TM.

J Geriatr Oncol. 2020 Mar 10. pii: S1879-4068(19)30393-5. doi: 10.1016/j.jgo.2020.03.005. [Epub ahead of print]

PMID:
32169544
2.

DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma.

Goldsmith SR, Fiala MA, Wang B, Schroeder MA, Wildes TM, Ghobadi A, Stockerl-Goldstein K, Vij R.

Ann Hematol. 2020 Mar 4. doi: 10.1007/s00277-020-03970-2. [Epub ahead of print]

PMID:
32130471
3.

Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma.

Sun J, Muz B, Alhallak K, Markovic M, Gurley S, Wang Z, Guenthner N, Wasden K, Fiala M, King J, Kohnen D, Salama NN, Vij R, Azab AK.

Cancers (Basel). 2020 Jan 28;12(2). pii: E305. doi: 10.3390/cancers12020305.

4.

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Du Z, Weinhold N, Song GC, Rand KA, Van Den Berg DJ, Hwang AE, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, Stram A, Berndt SI, Blot WJ, Casey G, Stevens VL, Kittles R, Goodman PJ, Diver WR, Hennis A, Nemesure B, Klein EA, Rybicki BA, Stanford JL, Witte JS, Signorello L, John EM, Bernstein L, Stroup AM, Stephens OW, Zangari M, Van Rhee F, Olshan A, Zheng W, Hu JJ, Ziegler R, Nyante SJ, Ingles SA, Press MF, Carpten JD, Chanock SJ, Mehta J, Colditz GA, Wolf J, Martin TG, Tomasson M, Fiala MA, Terebelo H, Janakiraman N, Kolonel L, Anderson KC, Le Marchand L, Auclair D, Chiu BC, Ziv E, Stram D, Vij R, Bernal-Mizrachi L, Morgan GJ, Zonder JA, Huff CA, Lonial S, Orlowski RZ, Conti DV, Haiman CA, Cozen W.

Blood Adv. 2020 Jan 14;4(1):181-190. doi: 10.1182/bloodadvances.2019000491.

5.

Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma.

Mian H, Fiala M, Wildes TM.

Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):98-104.e1. doi: 10.1016/j.clml.2019.09.618. Epub 2019 Oct 9.

PMID:
31843543
6.

Ruxolitinib for steroid-refractory acute graft-versus-host disease.

Toama W, Fiala M, Pusic I, Westervelt P, Dipersio JF, Schroeder M.

Transpl Int. 2020 Feb;33(2):244-246. doi: 10.1111/tri.13560. Epub 2019 Dec 13. No abstract available.

PMID:
31755139
7.

Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database.

Fakhri B, Fiala MA, Shah N, Vij R, Wildes TM.

Cancer. 2020 Feb 15;126(4):808-813. doi: 10.1002/cncr.32601. Epub 2019 Nov 13.

PMID:
31721140
8.

Heterotopic ossification: radiological and pathological review.

Mujtaba B, Taher A, Fiala MJ, Nassar S, Madewell JE, Hanafy AK, Aslam R.

Radiol Oncol. 2019 Sep 24;53(3):275-284. doi: 10.2478/raon-2019-0039. Review.

9.

EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms.

Goldsmith SR, Fiala MA, O'Neal J, Souroullas GP, Toama W, Vij R, Schroeder MA.

Clin Lymphoma Myeloma Leuk. 2019 Nov;19(11):744-750. doi: 10.1016/j.clml.2019.08.010. Epub 2019 Aug 30.

PMID:
31551170
10.

Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma.

Fiala MA, Vosuri V, Goldsmith S, Schroeder MA, Ghobadi A, Wildes TM, Stockerl-Goldstein KE, Vij R.

Bone Marrow Transplant. 2019 Aug 28. doi: 10.1038/s41409-019-0663-5. [Epub ahead of print] No abstract available.

PMID:
31462683
11.

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.

Muz B, Azab F, Fiala M, King J, Kohnen D, Fogler WE, Smith T, Magnani JL, Vij R, Azab AK.

Blood Cancer J. 2019 Aug 20;9(9):68. doi: 10.1038/s41408-019-0227-3. No abstract available.

12.

Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE score.

Sanfilippo KM, Luo S, Wang TF, Fiala M, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller J, Thomas T, Carson KR, Gage BF.

Am J Hematol. 2019 Nov;94(11):1176-1184. doi: 10.1002/ajh.25603. Epub 2019 Aug 19.

PMID:
31379000
13.

A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.

Ghobadi A, Fiala MA, Rettig M, Schroeder M, Uy GL, Stockerl-Goldstein K, Westervelt P, Vij R, DiPersio JF.

Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e588-e593. doi: 10.1016/j.clml.2019.04.017. Epub 2019 May 2.

PMID:
31358485
14.

A comparison of three different approaches to defining frailty in older patients with multiple myeloma.

Isaacs A, Fiala M, Tuchman S, Wildes TM.

J Geriatr Oncol. 2020 Mar;11(2):311-315. doi: 10.1016/j.jgo.2019.07.004. Epub 2019 Jul 17.

PMID:
31326393
15.

A Mixed-Methods Study of Stem Cell Transplantation Utilization for Newly Diagnosed Multiple Myeloma.

Fiala MA, Vij R, Wildes TM.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):e521-e525. doi: 10.1016/j.clml.2019.05.003. Epub 2019 May 13.

PMID:
31320252
16.

Cost differential associated with hospice use among older patients with multiple myeloma.

Fiala MA, Gettinger T, Wallace CL, Vij R, Wildes TM.

J Geriatr Oncol. 2020 Jan;11(1):88-92. doi: 10.1016/j.jgo.2019.06.010. Epub 2019 Jun 28.

PMID:
31262592
17.

Stereotactic radiosurgery for ablation of ventricular tachycardia.

Neuwirth R, Cvek J, Knybel L, Jiravsky O, Molenda L, Kodaj M, Fiala M, Peichl P, Feltl D, Januška J, Hecko J, Kautzner J.

Europace. 2019 Jul 1;21(7):1088-1095. doi: 10.1093/europace/euz133.

PMID:
31121018
18.

A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma.

Schroeder MA, Fiala MA, Huselton E, Cardone MH, Jaeger S, Jean SR, Shea K, Ghobadi A, Wildes T, Stockerl-Goldstein KE, Vij R.

Clin Cancer Res. 2019 Jul 1;25(13):3776-3783. doi: 10.1158/1078-0432.CCR-18-1909. Epub 2019 Apr 5.

PMID:
30952640
19.

African American patients may or may not have poorer response rates after monoclonal antibody treatment: Overreliance on P values in underpowered studies.

Fiala MA.

Cancer. 2019 Jul 1;125(13):2321-2322. doi: 10.1002/cncr.32082. Epub 2019 Mar 28. No abstract available.

PMID:
30919445
20.

Outcomes of patients with multiple myeloma refractory to CD38-targeted monoclonal antibody therapy.

Gandhi UH, Cornell RF, Lakshman A, Gahvari ZJ, McGehee E, Jagosky MH, Gupta R, Varnado W, Fiala MA, Chhabra S, Malek E, Mansour J, Paul B, Barnstead A, Kodali S, Neppalli A, Liedtke M, Narayana S, Godby KN, Kang Y, Kansagra A, Umyarova E, Scott EC, Hari P, Vij R, Usmani SZ, Callander NS, Kumar SK, Costa LJ.

Leukemia. 2019 Sep;33(9):2266-2275. doi: 10.1038/s41375-019-0435-7. Epub 2019 Mar 11.

21.

Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.

Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Schroeder MA, Tomasson M, Wildes TM, Vij R.

Clin Lymphoma Myeloma Leuk. 2019 May;19(5):285-289. doi: 10.1016/j.clml.2019.01.003. Epub 2019 Jan 19.

PMID:
30792096
22.

Challenges Associated With Living Remotely From a Pediatric Cancer Center: A Qualitative Study.

Walling EB, Fiala M, Connolly A, Drevenak A, Gehlert S.

J Oncol Pract. 2019 Mar;15(3):e219-e229. doi: 10.1200/JOP.18.00115. Epub 2019 Jan 31.

23.

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma.

Muz B, Buggio M, Azab F, de la Puente P, Fiala M, Padval MV, Weaver DT, Pachter JA, Vij R, Azab AK.

Haematologica. 2019 Jul;104(7):e310-e313. doi: 10.3324/haematol.2018.194688. Epub 2019 Jan 17. No abstract available.

24.
25.

Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases.

Jurczyszyn A, Davila J, Kortüm KM, Jayabalan DS, Vij R, Fiala M, Milunovic V, Chim CS, Wiśniewska-Piąty K, Waszczuk-Gajda A, Crusoe E, Hajek R, Robak P, Raźny M, Zawirska D, Bittrich M, Nahi H, Liu J, Castillo JJ, Vesole DH.

Leuk Lymphoma. 2019 Feb;60(2):471-476. doi: 10.1080/10428194.2018.1480766. Epub 2018 Jul 22.

PMID:
30033832
26.

Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment.

Malecek MK, Fiala M, Schroeder M, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Wildes T, Vij R.

Clin Lymphoma Myeloma Leuk. 2018 Sep;18(9):e363-e364. doi: 10.1016/j.clml.2018.06.008. Epub 2018 Jun 21. No abstract available.

PMID:
30001984
27.

Secondary plasma cell leukemia: a multicenter retrospective study of 101 patients.

Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grząśko N, Milunovic V, Hus I, Mądry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Dębski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charliński G, Gyula Szabo A, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH.

Leuk Lymphoma. 2019 Jan;60(1):118-123. doi: 10.1080/10428194.2018.1473574. Epub 2018 Jul 2.

PMID:
29965787
28.

Comparison of two modes of long-term ECG monitoring to assess the efficacy of catheter ablation for paroxysmal atrial fibrillation.

Chovancik J, Bulkova V, Wichterle D, Toman O, Rybka L, Januska J, Spinar J, Fiala M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2019 Feb;163(1):54-60. doi: 10.5507/bp.2018.031. Epub 2018 Jun 21.

29.

The Role of Visual Feedback on Power Output During Intermittent Wingate Testing in Ice Hockey Players.

Stastny P, Tufano JJ, Kregl J, Petr M, Blazek D, Steffl M, Roczniok R, Fiala M, Golas A, Zmijewski P.

Sports (Basel). 2018 Apr 9;6(2). pii: E32. doi: 10.3390/sports6020032.

30.

Impact assessment of traditional food manufacturing: The case of Grana Padano cheese.

Bava L, Bacenetti J, Gislon G, Pellegrino L, D'Incecco P, Sandrucci A, Tamburini A, Fiala M, Zucali M.

Sci Total Environ. 2018 Jun 1;626:1200-1209. doi: 10.1016/j.scitotenv.2018.01.143. Epub 2018 Feb 19.

PMID:
29898527
31.

The efficacy of salvage autologous stem cell transplant among patients with multiple myeloma who received maintenance therapy post initial transplant.

Manjappa S, Fiala MA, King J, Kohnen DA, Vij R.

Bone Marrow Transplant. 2018 Nov;53(11):1483-1486. doi: 10.1038/s41409-018-0216-3. Epub 2018 May 24. No abstract available.

PMID:
29795420
32.

A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5.

White BS, Lanc I, O'Neal J, Gupta H, Fulton RS, Schmidt H, Fronick C, Belter EA Jr, Fiala M, King J, Ahmann GJ, DeRome M, Mardis ER, Vij R, DiPersio JF, Levy J, Auclair D, Tomasson MH.

Blood Cancer J. 2018 Mar 21;8(3):35. doi: 10.1038/s41408-018-0062-y.

33.

Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.

Fakhri B, Fiala MA, Tuchman SA, Wildes TM.

Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):219-224. doi: 10.1016/j.clml.2018.01.005. Epub 2018 Jan 31.

34.

Cellular stressors contribute to the expansion of hematopoietic clones of varying leukemic potential.

Wong TN, Miller CA, Jotte MRM, Bagegni N, Baty JD, Schmidt AP, Cashen AF, Duncavage EJ, Helton NM, Fiala M, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, Vij R, DiPersio JF, Welch JS, Graubert TA, Walter MJ, Ley TJ, Link DC.

Nat Commun. 2018 Jan 31;9(1):455. doi: 10.1038/s41467-018-02858-0.

35.

Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.

Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grząśko N, Robak P, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charliński G, Szabo AG, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopińska-Posłuszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ.

Br J Haematol. 2018 Mar;180(6):831-839. doi: 10.1111/bjh.15092. Epub 2018 Jan 7.

PMID:
29315478
36.

Falls in older adults with multiple myeloma.

Wildes TM, Fiala MA.

Eur J Haematol. 2018 Mar;100(3):273-278. doi: 10.1111/ejh.13009. Epub 2018 Jan 8.

37.

Immunotherapy of Mild Cognitive Impairment by ω-3 Supplementation: Why Are Amyloid-β Antibodies and ω-3 Not Working in Clinical Trials?

Fiala M, Restrepo L, Pellegrini M.

J Alzheimers Dis. 2018;62(3):1013-1022. doi: 10.3233/JAD-170579. Review.

38.

Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin Lymphoma.

Bhamidipati PK, Fiala MA, Grossman BJ, DiPersio JF, Stockerl-Goldstein K, Gao F, Uy GL, Westervelt P, Schroeder MA, Cashen AF, Abboud CN, Vij R.

Biol Blood Marrow Transplant. 2017 Dec;23(12):2065-2069. doi: 10.1016/j.bbmt.2017.07.023. Epub 2017 Aug 7.

39.

Similar survival outcomes in patients with biclonal versus monoclonal myeloma: a multi-institutional matched case-control study.

Jurczyszyn A, Gozzetti A, Gdula-Argasińska J, Czepiel J, Vij R, Fiala M, Valls DJ, Mądry K, Waszczuk-Gajda A, Grosicki S, Barchnicka A, Crusoe E, Hungria V, Gentile M, Mele G, Ksieniewicz M, Vesole DH, Castillo JJ.

Ann Hematol. 2017 Oct;96(10):1693-1698. doi: 10.1007/s00277-017-3084-9. Epub 2017 Aug 1.

PMID:
28766002
40.

Two apparently remote types of ventricular tachycardia from a single right bundle branch focal source.

Josiek J, Januška J, Fiala M.

HeartRhythm Case Rep. 2017 Feb 24;3(5):264-267. doi: 10.1016/j.hrcr.2017.01.011. eCollection 2017 May. No abstract available.

41.

Omega-3 fatty acids increase the unfolded protein response and improve amyloid-β phagocytosis by macrophages of patients with mild cognitive impairment.

Olivera-Perez HM, Lam L, Dang J, Jiang W, Rodriguez F, Rigali E, Weitzman S, Porter V, Rubbi L, Morselli M, Pellegrini M, Fiala M.

FASEB J. 2017 Oct;31(10):4359-4369. doi: 10.1096/fj.201700290R. Epub 2017 Jun 20. Erratum in: FASEB J. 2017 Dec;31(12 ):5625.

42.

Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.

Muz B, Kusdono HD, Azab F, de la Puente P, Federico C, Fiala M, Vij R, Salama NN, Azab AK.

Leuk Lymphoma. 2017 Dec;58(12):2916-2925. doi: 10.1080/10428194.2017.1319052. Epub 2017 May 16.

43.

Catheter Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation.

Fiala M.

J Atr Fibrillation. 2016 Oct 31;9(3):1473. doi: 10.4022/jafib.1473. eCollection 2016 Oct-Nov. Review.

44.

Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Fiala M, Kooij G, Wagner K, Hammock B, Pellegrini M.

FASEB J. 2017 Aug;31(8):3229-3239. doi: 10.1096/fj.201700065R. Epub 2017 Apr 18. Review.

45.

IgM myeloma: A multicenter retrospective study of 134 patients.

Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA.

Am J Hematol. 2017 Aug;92(8):746-751. doi: 10.1002/ajh.24753. Epub 2017 May 26.

46.

Fresh or Cryopreserved CD34+-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function after Allogeneic Hematopoietic Cell Transplantation.

Ghobadi A, Fiala MA, Ramsingh G, Gao F, Abboud CN, Stockerl-Goldstein K, Uy GL, Grossman BJ, Westervelt P, DiPersio JF.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1072-1077. doi: 10.1016/j.bbmt.2017.03.019. Epub 2017 Mar 18.

47.

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML.

Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A.

Case Rep Hematol. 2017;2017:3728429. doi: 10.1155/2017/3728429. Epub 2017 Feb 20.

48.

Mobilization of allogeneic peripheral blood stem cell donors with intravenous plerixafor mobilizes a unique graft.

Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF.

Blood. 2017 May 11;129(19):2680-2692. doi: 10.1182/blood-2016-09-739722. Epub 2017 Mar 14.

49.

Conduction recovery following catheter ablation in patients with recurrent atrial fibrillation and heart failure.

Anselmino M, Matta M, Bunch TJ, Fiala M, Scaglione M, Nölker G, Qian P, Neumann T, Ferraris F, Gaita F.

Int J Cardiol. 2017 Aug 1;240:240-245. doi: 10.1016/j.ijcard.2017.02.067. Epub 2017 Feb 22.

50.

Racial disparities in treatment use for multiple myeloma.

Fiala MA, Wildes TM.

Cancer. 2017 May 1;123(9):1590-1596. doi: 10.1002/cncr.30526. Epub 2017 Jan 13.

Supplemental Content

Support Center